Multiple myeloma is a type of bone marrow cancer that affects the production of mature blood cells and weakens immune function. Multiple myeloma can affect any bones in which the bone marrow is active including the hips, pelvis, ribs, shoulders, skull and spine.
When the DNA of a plasma cell is damaged, the cell becomes abnormal. Abnormal plasma cells are called myeloma cells. An abnormal myeloma cell begins to divide rapidly, making many thousands of copies of itself.
Abnormal cells don’t develop, mature and die the way that normal cells do. Instead, they begin to accumulate into a mass of tissue called a tumor. After a while, myeloma cells will suppress the amount of normal blood cells in the bone marrow.
In healthy bone marrow, white blood cells mature into plasma cells, and each plasma cell makes a specific antibody to combat a specific antigen. However, myeloma cells produce only one type of antibody, called the monoclonal protein, or M protein.
As myeloma cells reproduce and spread, fewer and fewer healthy plasma cells are available to produce the variety of antibodies needed to fight off all the different antigens. This increases the risk of infection.
The five classifications of antibodies, also called immunoglobulins, are A, G, M, D and E. Although myeloma antibodies are called M proteins, not everyone with multiple myeloma overproduces immunoglobulin M (IgM). Multiple myeloma can involve an overproduction of any of the five antibody groups. An overproduction of IgG is the most common and an overproduction of IgE is the least common.
When a myeloma tumor becomes large enough, it can extend beyond the bone marrow and damage the solid, outer part of the bone and the surrounding tissue. In most cases, myeloma cells circulate throughout the body via the bloodstream and form tumors in bone marrow in multiple parts of the body. This is why the disease is called multiple myeloma. M proteins can travel through the bloodstream and affect other organs, particularly the kidneys.
Multiple myeloma is classified according to myeloma cancer pathology, as well as the presence and severity of myeloma symptoms, into these types:
Mayo Foundation for Medical Education and Research. (2009). Multiple myeloma: Causes. Retrieved September 24, 2010, from http://www.mayoclinic.com/health/multiple-myeloma/DS00415/DSECTION=causes
Myeloma Canada. (2010). Types of myeloma. Retrieved September 27, 2010, from http://www.myelomacanada.ca/en/typesofmyeloma.htm
Myeloma Institute for Research and Therapy. (n.d.). Basic pathology concepts of multiple myeloma. Retrieved September 24, 2010, from http://myeloma.uams.edu/about-myeloma/pathology.asp
National Cancer Institute. (2008). What is multiple myeloma? Retrieved September 23, 2010, from http://www.cancer.gov/cancertopics/wyntk/myeloma/page2
Seattle Cancer Care Alliance. (n.d.). Multiple myeloma facts. Retrieved September 24, 2010, from http://www.seattlecca.org/diseases/multiple-myeloma-facts.cfm
The Cancer Council NSW. (n.d.). Understanding multiple myeloma: Multiple myeloma explained. Retrieved September 24, 2010, from http://www.cancercouncil.com.au/editorial.asp?pageid=1105